Plain-English translation of NCT05642611 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether applying cooling and compression (pressure) to your arms and legs during taxane chemotherapy can prevent or reduce peripheral neuropathy—a type of nerve damage that causes numbness, tingling, and weakness in the hands and feet. You will be randomly assigned to receive one of three types of treatment: cooling plus compression, continuous compression alone, or gentle pulsing compression. Researchers will track how many people develop nerve damage over one year.
Taxane chemotherapy is effective at treating cancer, but it commonly causes nerve damage in the hands and feet that can be painful and long-lasting. This trial is testing whether mechanical cooling and compression during treatment can protect the nerves from this damage.
You likely qualify if…
You likely don't qualify if…
You will receive one of three types of cooling and compression therapy applied to your arms and legs: it starts 30 minutes before your chemotherapy infusion, continues during the infusion, and lasts 30 minutes after treatment ends. You'll repeat this with each chemotherapy session over your treatment course. You'll also complete questionnaires about any numbness, tingling, or weakness at weeks 6, 12, 24, and 52, and may have simple nerve function tests (like sensitivity checks and a brief movement test) to track any changes.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States